TherapeuticsMD (TXMD) Assets Average (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Assets Average came in at $37.6 million in Q1 2026, down 2.36% YoY from $38.5 million in Q1 2025, and down 1.43% on a QoQ basis from $38.2 million in Q4 2025.
TherapeuticsMD (TXMD) Assets Average (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 15 years of Assets Average data on file, last reported at $37.6 million in Q1 2026.
- Quarterly Assets Average fell 2.36% year-over-year to $37.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.6 million (down 2.36% YoY) and the FY2025 annual result came in at $38.2 million, down 6.88% from the prior year.
- Assets Average slipped to $37.6 million in Q1 2026, from $38.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $151.4 million in Q1 2022 to a low of $37.6 million in Q1 2026.
- A 5-year average of $66.4 million and a median of $42.7 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average sank 62.81% — and 2026, when it decreased 2.36%.
- Tracing TXMD's Assets Average over 5 years: stood at $112.2 million in 2022, then tumbled by 58.19% to $46.9 million in 2023, then slipped by 16.45% to $39.2 million in 2024, then decreased by 2.61% to $38.2 million in 2025, then declined by 1.43% to $37.6 million in 2026.
- The last three Assets Average figures came in at $37.6 million (Q1 2026), $38.2 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 37.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.56 Mn |
| Mar 31, 2026 | 37.62 Mn |
| Dec 31, 2025 | 38.16 Mn |
| Sep 30, 2025 | 38.59 Mn |
| Jun 30, 2025 | 38.37 Mn |
| Mar 31, 2025 | 38.53 Mn |
| Dec 31, 2024 | 39.19 Mn |
| Sep 30, 2024 | 39.84 Mn |
| Jun 30, 2024 | 41.11 Mn |
| Mar 31, 2024 | 42.70 Mn |
| Dec 31, 2023 | 46.90 Mn |
| Sep 30, 2023 | 52.09 Mn |
| Jun 30, 2023 | 56.65 Mn |
| Mar 31, 2023 | 75.03 Mn |
| Dec 31, 2022 | 112.18 Mn |
| Sep 30, 2022 | 140.05 Mn |
| Jun 30, 2022 | 139.79 Mn |
| Mar 31, 2022 | 151.43 Mn |
| Dec 31, 2021 | 189.55 Mn |
| Sep 30, 2021 | 210.11 Mn |